Soleno Therapeutics's market cap is currently $2.71B. The company's EPS TTM is $-0.09; its P/E ratio is ―; Soleno Therapeutics is scheduled to report earnings on August 6, 2025, and the estimated EPS forecast is $0.04. See an overview of income statement, balance sheet, and cash flow financials.
